SanjayNavinMediwalaMD

Endocrinology • Houston, TX

Diabetes, Lipid Metabolism

Instructor, Endocrinology, Baylor College of Medicine

Join to view full profile

Dr. Mediwala is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mediwala's full profile

Already have an account?

Office
2002 Holcombe Blvd
Room 3b-174
Houston, TX 77030
Phone+1 713-794-7151

Education & Training

Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2009
Baylor College of MedicineResidency, Internal Medicine, 2000 - 2003
Baylor College of MedicineClass of 2000

Certifications & Licensure

TX State Medical License 2003 - 2025

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

19 citations
Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects
Georgia Colleluori, Rui Chen, Christie G Turin, Francesca Vigevano, Clifford Qualls
Frontiers in Endocrinology. 2020-05-15
18 citations
Lifestyle Intervention Strategy to Treat Diabetes in Older Adults: A Randomized Controlled Trial.
Alessandra Celli, Yoann Barnouin, Bryan Jiang, Dean Blevins, Georgia Colleluori
Diabetes Care. 2022-09-01
15 citations
CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy.
Huiying Sun, Sanjay N. Mediwala, Adam T. Szafran, Michael A. Mancini, Marco Marcelli
Hormones & Cancer. 2016-03-08